APEX1 and bacterial infectious disease: SlTLP5 and SlTLP6 knockout experiments in the resistant “S-55” cultivar revealed that there was little difference in APX, POD, and SOD activities toward ROS (Figure 7), and CAT activity increased and decreased in fungal and bacterial diseases, respectively, indicating that ROS possessed different regulatory pathways in the TLP disease resistance mechanism.